Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo
- Mandy L. Ballinger
- , Narin Osman
- , Kazuhiko Hashimura
- , Judy B.de Haan
- , Karin Jandeleit-Dahm
- , Terri Allen
- , Lisa R. Tannock
- , John C. Rutledge
- , Peter J. Little
Producción científica: Article › revisión exhaustiva
59
Citas
(Scopus)